EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieRandomisierte kontrollierte Studie

Intermittent Corticosteroid Maintenance Treatment of Psoriasis: A Double-Blind Multicenter Trial of Augmented Betamethasone Dipropionate Ointment in a Pulse Dose Treatment Regimen

H I Katz, S E Prawer, R S Medansky, G G Krueger, J J Mooney, M L Jones, C R Samson

Dermatologica · 08.10.2009 · 269-274

DOI: 10.1159/000247698 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Dermatologica, online erschienen am 08.10.2009. Verfasst von H I Katz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Minnesota Clinical Study Center, Fridley. Die Arbeit wurde bisher 60-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ninety psoriasis patients, who were either completely cleared of or manifested only a minimal presence of disease signs following 3–4 weeks of twice daily treatment with augmented betamethasone dipropionate (ABD) ointment 0.05%, were enrolled in this multicenter, double-blind, placebo-controlled study. The study was designed to determine if an intermittent pulse dose regimen of ABD ointment could safely and effectively maintain a remission disease status when treatment was applied in three consecutive applications 12 h apart, once a week for a maximum treatment period of 6 months. The disease of 60% of the patients in the active treatment group was successfully controlled for 6 months, while 80% of the placebo-treated patients experienced exacerbation of disease signs. No serious local or systemic treatment-related adverse experiences were reported. ABD ointment 0.05% when applied using the intermittent treatment regimen described here, was shown to be a clinically beneficial and well-tolerated method of long-term (up to 6 months) maintenance therapy for psoriasis patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Administration, TopicalAdultAgedAged, 80 and overAnti-Inflammatory AgentsBetamethasoneDouble-Blind MethodDrug Administration ScheduleFemaleHumansHydrocortisoneMaleMiddle AgedOintmentsPsoriasisTime Factors

Substanzen

Anti-Inflammatory AgentsOintmentsbetamethasone-17,21-dipropionateBetamethasoneHydrocortisone

Autor:innen und Institutionen

  • Minnesota Clinical Study Center, Fridley.

Zitieren

APA

Katz, H. I., Prawer, S. E., Medansky, R. S., Krueger, G. G., Mooney, J. J., Jones, M. L., & Samson, C. R. (2009). Intermittent Corticosteroid Maintenance Treatment of Psoriasis: A Double-Blind Multicenter Trial of Augmented Betamethasone Dipropionate Ointment in a Pulse Dose Treatment Regimen. Dermatologica, 269-274. https://doi.org/10.1159/000247698

Vancouver

Katz HI, Prawer SE, Medansky RS, Krueger GG, Mooney JJ, Jones ML, et al. Intermittent Corticosteroid Maintenance Treatment of Psoriasis: A Double-Blind Multicenter Trial of Augmented Betamethasone Dipropionate Ointment in a Pulse Dose Treatment Regimen. Dermatologica. 2009:269-274. doi:10.1159/000247698

BibTeX
@article{Katz2009,
  author = {Katz, H I and Prawer, S E and Medansky, R S and Krueger, G G and Mooney, J J and Jones, M L and Samson, C R},
  title = {Intermittent Corticosteroid Maintenance Treatment of Psoriasis: A Double-Blind Multicenter Trial of Augmented Betamethasone Dipropionate Ointment in a Pulse Dose Treatment Regimen},
  journal = {Dermatologica},
  year = {2009},
  pages = {269--274},
  doi = {10.1159/000247698}
}
Kostenlos starten →